Common occurrence of antibacterial agents in human intestinal microbiota.
Level 5 - mechanism / opinion, no new human data
In silico bioinformatic analysis of bacterial genomes (by design analogy, not clinical CEBM)
PubMed 25999943 · doi:10.3389/fmicb.2015.00441
What was done
Identified and classified putative bacteriocin-encoding genes across 317 microbial genomes from the human intestine using sequence homology to known bacteriocins (principally from lactic acid bacteria). Analyzed their predicted class distribution, net charge, hydrophobicity, and secondary structure across phyla.
What was found
Putative bacteriocins were detected across four major gut phyla: 175 in Firmicutes, 79 in Proteobacteria, 34 in Bacteroidetes, and 25 in Actinobacteria. The predicted peptides differed widely in net positive charge, hydrophobicity, and class distribution across phyla, though the alpha-helix was the predominant secondary structure.
Why it matters
Demonstrates that antimicrobial peptide-encoding genes are broadly distributed across human gut microbiota, highlighting their potential role in intra-community competition and as a source for novel antimicrobial discovery.
Limits
The study is entirely in silico and relies on sequence homology. It did not experimentally measure peptide expression, antimicrobial potency, target spectrum, or functional ecological roles in the human gastrointestinal tract. Analyzed a finite set of 317 genomes.
Cited by
- supports Certain bacteria in the microbiome secrete antimicrobial peptides that function as natural antibiotics to inhibit competing bacterial species.